Ask Tybjaerg Tybjaerg Nordestgaard, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coffee | 6 | 2022 | 598 | 2.040 |
Why?
|
| Gallstones | 2 | 2021 | 285 | 1.170 |
Why?
|
| Erythrocyte Transfusion | 2 | 2020 | 575 | 0.950 |
Why?
|
| Mendelian Randomization Analysis | 6 | 2022 | 1037 | 0.840 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 643 | 0.520 |
Why?
|
| Intraoperative Care | 1 | 2019 | 771 | 0.510 |
Why?
|
| Caffeine | 2 | 2017 | 702 | 0.500 |
Why?
|
| Denmark | 5 | 2024 | 779 | 0.440 |
Why?
|
| Surgical Procedures, Operative | 4 | 2020 | 1937 | 0.290 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2019 | 89 | 0.290 |
Why?
|
| Smoking | 2 | 2022 | 9111 | 0.270 |
Why?
|
| Emergency Treatment | 2 | 2021 | 496 | 0.260 |
Why?
|
| Postoperative Complications | 6 | 2024 | 15881 | 0.260 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2139 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 12241 | 0.230 |
Why?
|
| Obesity | 3 | 2021 | 13084 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8747 | 0.180 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 1673 | 0.170 |
Why?
|
| Stroke | 1 | 2021 | 9742 | 0.160 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 1765 | 0.160 |
Why?
|
| Alleles | 3 | 2019 | 6892 | 0.150 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 120 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 2017 | 103 | 0.140 |
Why?
|
| Risk Factors | 8 | 2022 | 74962 | 0.140 |
Why?
|
| Appendicitis | 1 | 2024 | 689 | 0.140 |
Why?
|
| Blood Component Transfusion | 1 | 2017 | 141 | 0.140 |
Why?
|
| Shock, Hemorrhagic | 1 | 2017 | 224 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 68 | 0.120 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 387 | 0.120 |
Why?
|
| Middle Aged | 13 | 2022 | 223491 | 0.110 |
Why?
|
| Malnutrition | 1 | 2020 | 631 | 0.110 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 3836 | 0.110 |
Why?
|
| Resuscitation | 1 | 2017 | 679 | 0.100 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 221 | 0.100 |
Why?
|
| Genetic Variation | 2 | 2019 | 6606 | 0.100 |
Why?
|
| Genes | 1 | 2016 | 1824 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 1422 | 0.100 |
Why?
|
| Clostridium Infections | 1 | 2019 | 560 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 22385 | 0.100 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 621 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2024 | 2056 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2020 | 1627 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2017 | 809 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 1459 | 0.090 |
Why?
|
| Aged | 11 | 2021 | 171562 | 0.090 |
Why?
|
| Self Report | 1 | 2022 | 3766 | 0.090 |
Why?
|
| Male | 16 | 2024 | 364902 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2018 | 873 | 0.090 |
Why?
|
| Length of Stay | 2 | 2024 | 6519 | 0.080 |
Why?
|
| Female | 16 | 2024 | 397089 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1141 | 0.080 |
Why?
|
| United States | 7 | 2021 | 73150 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2006 | 0.080 |
Why?
|
| Appendectomy | 2 | 2024 | 443 | 0.070 |
Why?
|
| Humans | 18 | 2024 | 768393 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2912 | 0.070 |
Why?
|
| General Surgery | 1 | 2018 | 1713 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2018 | 1946 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1901 | 0.070 |
Why?
|
| Adult | 9 | 2024 | 223640 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 13323 | 0.060 |
Why?
|
| Mortality | 1 | 2016 | 2917 | 0.060 |
Why?
|
| Genotype | 1 | 2019 | 13042 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4250 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 7955 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12092 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12558 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2015 | 6430 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2015 | 8541 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39407 | 0.040 |
Why?
|
| Chemokine CCL4 | 1 | 2017 | 127 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 13052 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 59686 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 501 | 0.030 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2018 | 236 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 348 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 371 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2024 | 2168 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2020 | 24318 | 0.030 |
Why?
|
| Emergencies | 1 | 2019 | 1219 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 1364 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81801 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 1020 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3813 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1813 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5878 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5151 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 2188 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18471 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65379 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7453 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4875 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21544 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15939 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54920 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 60049 | 0.010 |
Why?
|